Your browser doesn't support javascript.
loading
A Targeted Mass Spectrometry Strategy for Developing Proteomic Biomarkers: A Case Study of Epithelial Ovarian Cancer.
Hüttenhain, Ruth; Choi, Meena; Martin de la Fuente, Laura; Oehl, Kathrin; Chang, Ching-Yun; Zimmermann, Anne-Kathrin; Malander, Susanne; Olsson, Håkan; Surinova, Silvia; Clough, Timothy; Heinzelmann-Schwarz, Viola; Wild, Peter J; Dinulescu, Daniela M; Niméus, Emma; Vitek, Olga; Aebersold, Ruedi.
Afiliação
  • Hüttenhain R; ‡Department of Biology, Institute of Molecular Systems Biology, ETH Zurich, 8093 Zurich, Switzerland. Electronic address: ruth.huttenhain@ucsf.edu.
  • Choi M; §Khoury College of Computer Sciences, Northeastern University, Boston, MA.
  • Martin de la Fuente L; ¶Department of Surgery and Oncology, Clinical Sciences, Lund University, Lund, Sweden.
  • Oehl K; ‖Department of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland.
  • Chang CY; **Department of Statistics, Purdue University, West Lafayette, IN.
  • Zimmermann AK; ‖Department of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland.
  • Malander S; ¶Department of Surgery and Oncology, Clinical Sciences, Lund University, Lund, Sweden.
  • Olsson H; ¶Department of Surgery and Oncology, Clinical Sciences, Lund University, Lund, Sweden.
  • Surinova S; ‡Department of Biology, Institute of Molecular Systems Biology, ETH Zurich, 8093 Zurich, Switzerland.
  • Clough T; **Department of Statistics, Purdue University, West Lafayette, IN.
  • Heinzelmann-Schwarz V; ‡‡Gynecological Cancer Center, University Hospital Basel, University of Basel, Basel, Switzerland; §§Ovarian Cancer Research, Department of Biomedicine, University of Basel, Basel, Switzerland.
  • Wild PJ; ¶¶Dr. Senckenberg Institute of Pathology, University Hospital Frankfurt, Frankfurt am Main, Germany.
  • Dinulescu DM; ‖‖Department of Pathology, Division of Women's and Perinatal Pathology Brigham and Women's Hospital Harvard Medical School, Boston, MA.
  • Niméus E; ¶Department of Surgery and Oncology, Clinical Sciences, Lund University, Lund, Sweden; ‡‡‡Department of Surgery, Skånes University hospital, Lund, Sweden.
  • Vitek O; §Khoury College of Computer Sciences, Northeastern University, Boston, MA; **Department of Statistics, Purdue University, West Lafayette, IN.
  • Aebersold R; ‡Department of Biology, Institute of Molecular Systems Biology, ETH Zurich, 8093 Zurich, Switzerland; §§§Faculty of Science, University of Zurich, 8057 Zurich, Switzerland.
Mol Cell Proteomics ; 18(9): 1836-1850, 2019 09.
Article em En | MEDLINE | ID: mdl-31289117

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Espectrometria de Massas / Biomarcadores Tumorais / Proteômica / Carcinoma Epitelial do Ovário Tipo de estudo: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Animals / Female / Humans Idioma: En Revista: Mol Cell Proteomics Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Espectrometria de Massas / Biomarcadores Tumorais / Proteômica / Carcinoma Epitelial do Ovário Tipo de estudo: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Animals / Female / Humans Idioma: En Revista: Mol Cell Proteomics Ano de publicação: 2019 Tipo de documento: Article